Integration and Challenges of Excipients with Pharmacological Efficacy

赋形剂 活性成分 药品 药理学 生化工程 风险分析(工程) 医学 工程类
作者
Haosheng Zhang
标识
DOI:10.54097/hset.v66i.11712
摘要

Excipients are extra compounds that are included with the primary active ingredients in medicinal products. They are essential in enhancing the stability and accessibility of medications. Although excipients are a common component of daily life, incorporating them with pharmaceuticals still offers some difficulties. Although there are many different kinds of excipients, not all of them can completely match a medicine. Excipients will be used in diverse ways as carriers as a result of the various pharmaceutical production methods, which will modify the excipients that are chosen. Excipients often engage in the body's absorption and metabolism just like active pharmaceutical substances do. Different excipients have been tested in vitro and in vivo by researchers. They matched in vitro activity tests of 25 excipients to clinical safety tests. As a result, they discovered an extra 109 activities. Many individuals now understand that considering excipient toxicity is important. Researchers integrated it with cell models in animal trials and discovered that five excipients can predict the fingerprint of systemic toxicity. Additional research is required on the exposure of seven excipients, including thimerosal intestine exposure. Effect and risk ratio are two factors that are taken into consideration while assessing an excipient's safety. When examining a patient's response to a medication and how it varies, drug researchers may come across a range of circumstances. This article's objectives are to introduce the idea of excipients, examine some typical excipient usage instances, and provide an overview of excipient use in pharmaceuticals. Drug development is a dynamic process that is always changing. Although excipients have been employed in therapeutic settings, there are still a great deal of undiscovered excipients that require further study, analysis, and summarization.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
干羞花完成签到,获得积分10
刚刚
刚刚
刚刚
李惊鸿发布了新的文献求助30
1秒前
十二完成签到,获得积分10
2秒前
3秒前
carly发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
西番雅完成签到,获得积分10
5秒前
dxc完成签到 ,获得积分10
5秒前
撒玉发布了新的文献求助10
5秒前
zhou发布了新的文献求助10
5秒前
大个应助快乐小饭包采纳,获得10
7秒前
西番雅发布了新的文献求助10
9秒前
9秒前
9秒前
GHOU完成签到,获得积分10
10秒前
一一发布了新的文献求助10
12秒前
hjl完成签到 ,获得积分10
12秒前
何处芳歇完成签到,获得积分10
13秒前
13秒前
传奇3应助忧伤的慕梅采纳,获得10
14秒前
飘123发布了新的文献求助10
14秒前
Janet_Jing完成签到 ,获得积分10
15秒前
李惊鸿完成签到,获得积分10
15秒前
SunJc完成签到,获得积分10
16秒前
17秒前
18秒前
彭于晏应助kkk采纳,获得10
18秒前
21秒前
慕子完成签到 ,获得积分10
22秒前
22秒前
22秒前
共享精神应助科研通管家采纳,获得10
23秒前
局内人发布了新的文献求助10
23秒前
搜集达人应助科研通管家采纳,获得10
23秒前
方赫然应助科研通管家采纳,获得10
23秒前
Ava应助科研通管家采纳,获得10
23秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
錢鍾書楊絳親友書札 600
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3295946
求助须知:如何正确求助?哪些是违规求助? 2931781
关于积分的说明 8453689
捐赠科研通 2604382
什么是DOI,文献DOI怎么找? 1421675
科研通“疑难数据库(出版商)”最低求助积分说明 661111
邀请新用户注册赠送积分活动 644031